RALEIGH, N.C. & TARRYTOWN, N.Y.-- --Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals today reported that the Anesthetic and Analgesic Drug Products Advisory Committee of the Food and Drug Administration has provided an assessment of potential cardiovascular risk associated with products in the class of peripherally-active opioid receptor ... (more)
http://ift.tt/1oTC9P6
http://ift.tt/1oTC9P6
No comments:
Post a Comment